Stock News

As Metlife Com (MET) Stock Rose, Churchill Management Boosted Position by $475,110; Boston Scientific (BSX) Shareholder Bollard Group Decreased Its Holding

MetLife, Inc. (NYSE:MET) Logo

Bollard Group Llc decreased its stake in Boston Scientific Corp (BSX) by 0.59% based on its latest 2018Q1 regulatory filing with the SEC. Bollard Group Llc sold 199,076 shares as the company’s stock rose 9.74% while stock markets declined. The hedge fund held 33.66 million shares of the medical and dental instruments company at the end of 2018Q1, valued at $919.46M, down from 33.85 million at the end of the previous reported quarter. Bollard Group Llc who had been investing in Boston Scientific Corp for a number of months, seems to be less bullish one the $44.39 billion market cap company. The stock increased 0.78% or $0.25 during the last trading session, reaching $32.17. About 287,420 shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 11.19% since June 20, 2017 and is uptrending. It has underperformed by 1.38% the S&P500. Some Historical BSX News: 30/04/2018 – BOSTON SCIENTIFIC CLOSES NXTHERA PURCHASE; 09/03/2018 – MOODY’S: OUTLOOK FOR US MEDICAL PRODUCTS AND DEVICES INDUSTRY CHANGED TO POSITIVE; 23/03/2018 – Edwards Prevails In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims lnvalid; 21/03/2018 – BOSTON SCIENTIFIC – TRANSACTION ALSO CONSISTS OF UP TO ADDITIONAL $100 MLN IN POTENTIAL COMMERCIAL MILESTONE PAYMENTS OVER NEXT FOUR YEARS; 25/04/2018 – Boston Scientific 1Q Adj EPS 33c; 16/05/2018 – SCV Signal [Reg]: Hart athletes helped by donation from Boston Scientific; 16/04/2018 – Boston Scientific Sees Deal Immaterial to Adjusted EPS in 2018, 2019; 23/04/2018 – Boston Scientific Corp expected to post earnings of 32 cents a share – Earnings Preview; 25/04/2018 – Boston Scientific Raises 2018 View To Adj EPS $1.37-Adj EPS $1.41; 21/03/2018 – BOSTON SCIENTIFIC CORP – TRANSACTION CONSISTS OF AN UPFRONT CASH PAYMENT OF $306 MLN

Churchill Management Corp increased its stake in Metlife Inc Com (MET) by 37.3% based on its latest 2018Q1 regulatory filing with the SEC. Churchill Management Corp bought 10,558 shares as the company’s stock rose 0.25% while stock markets declined. The institutional investor held 38,867 shares of the finance company at the end of 2018Q1, valued at $1.78M, up from 28,309 at the end of the previous reported quarter. Churchill Management Corp who had been investing in Metlife Inc Com for a number of months, seems to be bullish on the $46.51 billion market cap company. The stock increased 0.05% or $0.02 during the last trading session, reaching $45.75. About 329,587 shares traded. MetLife, Inc. (NYSE:MET) has risen 4.50% since June 20, 2017 and is uptrending. It has underperformed by 8.07% the S&P500. Some Historical MET News: 01/05/2018 – METLIFE’S GOULART COMMENTS IN BLOOMBERG TELEVISION INTERVIEW; 26/04/2018 – MetLife CEO Issues Another Mea Culpa for Recent String of Errors; 05/04/2018 – METLIFE 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors of Deadline in Class Action Lawsuit against MetLife, Inc. – MET; 02/05/2018 – Lucens Group appoints former MetLife executive as President & Chief Operating Officer; 02/05/2018 – MetLife: 1Q Driven by Favorable Underwriting, Volume Growth, Effects of Tax Reform; 30/05/2018 – Local Economic Outlook Pushes Small Business Optimism to Record High; 03/04/2018 – METLIFE 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against MetLife, Inc; 18/04/2018 – MetLife Investment Management Reaches a Record $11.2 B in Private Debt Origination in 2017; 14/05/2018 – MEDIA-India’s PNB revives plan to list life cover arm – Economic Times; 02/05/2018 – MetLife 1Q Asia Total Adjusted Earnings Up 11%

More important recent MetLife, Inc. (NYSE:MET) news were published by: Globenewswire.com which released: “Lawsuit for Investors in NYSE: MET shares against MetLife announced by Shareholders Foundation” on May 30, 2018, also Seekingalpha.com published article titled: “MetLife: This 5.625% Preferred Stock Has Begun Trading On The NYSE”, Businesswire.com published: “MetLife Completes Debt-for-Equity Exchange for Its Retained Brighthouse Financial, Inc. Common Stock” on June 19, 2018. More interesting news about MetLife, Inc. (NYSE:MET) was released by: Streetinsider.com and their article: “Monument Re Buys Portfolio From Metlife Europe DAC (MET)” with publication date: June 20, 2018.

Among 19 analysts covering MetLife (NYSE:MET), 9 have Buy rating, 1 Sell and 9 Hold. Therefore 47% are positive. MetLife had 59 analyst reports since July 31, 2015 according to SRatingsIntel. On Monday, January 23 the stock rating was upgraded by Deutsche Bank to “Buy”. The company was maintained on Friday, May 4 by Deutsche Bank. On Wednesday, November 11 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. Atlantic Securities upgraded the stock to “Overweight” rating in Monday, March 26 report. FBR Capital downgraded MetLife, Inc. (NYSE:MET) on Tuesday, October 10 to “Neutral” rating. As per Thursday, December 21, the company rating was maintained by Keefe Bruyette & Woods. The rating was maintained by FBR Capital on Monday, August 29 with “Outperform”. On Tuesday, September 5 the stock rating was maintained by RBC Capital Markets with “Buy”. FBR Capital upgraded MetLife, Inc. (NYSE:MET) on Thursday, May 25 to “Outperform” rating. Wells Fargo maintained the stock with “Buy” rating in Wednesday, April 19 report.

Churchill Management Corp, which manages about $3.45 billion and $3.45B US Long portfolio, decreased its stake in Spdr Dow Jones Indl Avrg Etf U (DIA) by 623,287 shares to 1.73M shares, valued at $416.52M in 2018Q1, according to the filing. It also reduced its holding in Ishares Msci Eafe E (EFA) by 3.28 million shares in the quarter, leaving it with 76,897 shares, and cut its stake in Netflix Inc Com (NASDAQ:NFLX).

Investors sentiment decreased to 0.72 in Q1 2018. Its down 0.30, from 1.02 in 2017Q4. It is negative, as 101 investors sold MET shares while 352 reduced holdings. 79 funds opened positions while 247 raised stakes. 766.37 million shares or 2.12% less from 782.94 million shares in 2017Q4 were reported. Shufro Rose Co Limited Liability owns 1.53% invested in MetLife, Inc. (NYSE:MET) for 336,974 shares. Natixis has invested 0.06% in MetLife, Inc. (NYSE:MET). Valley National Advisers reported 1,417 shares. Cibc Fincl Bank Usa owns 10,800 shares. Next owns 6,407 shares for 0.06% of their portfolio. Exxonmobil Inv Tx invested in 0.21% or 158,699 shares. Pinnacle Associate Ltd, New York-based fund reported 273,089 shares. Atria Invests Ltd Llc holds 78,752 shares. Linden Limited Partnership has invested 0.58% of its portfolio in MetLife, Inc. (NYSE:MET). Ckw Financial Grp Incorporated holds 0.03% or 2,729 shares in its portfolio. Wells Fargo Company Mn holds 6.12M shares. 1St Source National Bank has 38,559 shares for 0.15% of their portfolio. Lsv Asset Mgmt holds 0.28% or 3.81M shares in its portfolio. Vanguard invested in 0.14% or 68.18M shares. Cibc invested in 0.04% or 220,133 shares.

Since December 29, 2017, it had 0 insider buys, and 22 selling transactions for $12.46 million activity. Pierce David A sold 5,000 shares worth $135,958. Butcher Arthur C also sold $225,413 worth of Boston Scientific Corporation (NYSE:BSX) shares. Mirviss Jeffrey B. also sold $630,703 worth of Boston Scientific Corporation (NYSE:BSX) on Thursday, June 14. Thepaut Eric Francis Yves sold $603,368 worth of stock. Ballinger Kevin J. had sold 31,056 shares worth $931,680. 15,835 shares were sold by Phalen Michael P., worth $399,865.

Among 33 analysts covering Boston Scientific Corporation (NYSE:BSX), 27 have Buy rating, 0 Sell and 6 Hold. Therefore 82% are positive. Boston Scientific Corporation had 101 analyst reports since July 27, 2015 according to SRatingsIntel. The company was maintained on Thursday, July 27 by Cowen & Co. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Neutral” rating by Wedbush on Thursday, April 28. Needham maintained Boston Scientific Corporation (NYSE:BSX) on Friday, April 28 with “Buy” rating. On Friday, July 28 the stock rating was maintained by Oppenheimer with “Hold”. The firm has “Buy” rating by Nomura given on Thursday, March 17. Raymond James maintained Boston Scientific Corporation (NYSE:BSX) rating on Thursday, April 26. Raymond James has “Strong Buy” rating and $34 target. RBC Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, June 9. RBC Capital Markets has “Outperform” rating and $31 target. BMO Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, October 27. BMO Capital Markets has “Outperform” rating and $32 target. The firm has “Buy” rating by Piper Jaffray given on Friday, February 23. The firm earned “Neutral” rating on Thursday, August 27 by Goldman Sachs.

Investors sentiment decreased to 0.96 in Q1 2018. Its down 0.38, from 1.34 in 2017Q4. It is negative, as 42 investors sold BSX shares while 181 reduced holdings. 60 funds opened positions while 153 raised stakes. 1.18 billion shares or 0.46% less from 1.18 billion shares in 2017Q4 were reported. Moreover, Manatuck Hill Prtn Limited Liability Company has 0.18% invested in Boston Scientific Corporation (NYSE:BSX). Johnson Financial Grp Inc holds 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 687 shares. Pub Employees Retirement System Of Ohio has 0.13% invested in Boston Scientific Corporation (NYSE:BSX). Adage Capital Ptnrs Grp Lc owns 2.34M shares. 323,400 were accumulated by Deltec Asset Management Ltd Liability Corp. The North Carolina-based Smith Salley & Assocs has invested 0.04% in Boston Scientific Corporation (NYSE:BSX). Illinois-based Continental Ltd Liability Corporation has invested 0.4% in Boston Scientific Corporation (NYSE:BSX). Ww Asset owns 92,622 shares. Axa invested 0.13% of its portfolio in Boston Scientific Corporation (NYSE:BSX). The New York-based Art Advsr Limited Liability has invested 0.24% in Boston Scientific Corporation (NYSE:BSX). Japan-based Norinchukin Commercial Bank The has invested 0.06% in Boston Scientific Corporation (NYSE:BSX). Zeke Advsrs Ltd Company reported 26,042 shares. Schroder Management Grp accumulated 0.01% or 166,922 shares. Moreover, Tiverton Asset Mgmt Limited Liability Corporation has 0.04% invested in Boston Scientific Corporation (NYSE:BSX). Amalgamated Fincl Bank, New York-based fund reported 200,561 shares.

Bollard Group Llc, which manages about $2.78B and $2.01B US Long portfolio, upped its stake in Martin Midstream Partners Lp (NASDAQ:MMLP) by 39,100 shares to 54,950 shares, valued at $742,000 in 2018Q1, according to the filing. It also increased its holding in Merck & Co Inc (NYSE:MRK) by 6,793 shares in the quarter, for a total of 98,444 shares, and has risen its stake in Johnson Controls Intl Plc.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on July, 26. They expect $0.34 EPS, up 6.25% or $0.02 from last year’s $0.32 per share. BSX’s profit will be $469.13M for 23.65 P/E if the $0.34 EPS becomes a reality. After $0.33 actual EPS reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts 3.03% EPS growth.

More important recent Boston Scientific Corporation (NYSE:BSX) news were published by: Seekingalpha.com which released: “Boston Scientific Is A Good Earnings Story – Cramer’s Lightning Round (6/13/18)” on June 14, 2018, also Bizjournals.com published article titled: “Only four DC-area CEOs make Glassdoor’s top 100 list for 2018”, Streetinsider.com published: “Stryker (SYK) is not in discussions with Boston Scientific (BSX)” on June 13, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) was released by: Streetinsider.com and their article: “Stryker (SYK) Made Takeover Approach for Boston Scientific (BSX) – WSJ” with publication date: June 11, 2018.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *